Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.14 - $2.97 $12,311 - $32,076
-10,800 Reduced 60.34%
7,100 $9,000
Q1 2024

May 13, 2024

SELL
$1.95 - $4.04 $52,260 - $108,272
-26,800 Reduced 59.96%
17,900 $50,000
Q4 2023

Feb 08, 2024

BUY
$2.32 - $5.51 $4,408 - $10,469
1,900 Added 4.44%
44,700 $131,000
Q3 2023

Nov 01, 2023

BUY
$2.49 - $11.85 $106,572 - $507,180
42,800 New
42,800 $108,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $12.6M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.